Search Results 941-950 of 18581 for Prednisone

1. RP2/RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRC - Mayo Clinic

   only if the dose does not exceed 10 mg/day prednisone equivalent. 21. Conditions in which anticoagulant therapies cannot be safely stopped in the

2. A Study Of The Gala Airway Treatment System For The Treatment Of Chronic Bronchitis In The United States - Mayo Clinic

   Subject is taking > 10 mg of prednisolone or prednisone per day. Subject has an implantable cardioverter defibrillator or pacemaker. Subject has a history ...

3. Tacrolimus (topical route) - Mayo Clinic

   Atopic dermatitis is a skin condition where there is itching, redness, and inflammation, much like an allergic reaction. Tacrolimus helps to suppress these ...

4. A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower130) - Mayo Clinic

   ... prednisone or equivalent), systemic immunosuppressant medications may be enrolled in the study. The use of corticosteroids (≤ 10 mg oral prednisone or ...

5. A Study to Estimate the Clinical Benefit of REGN2810 for Patients with Advanced Squamous Cell Skin Cancer

   Immunosuppressive corticosteroid doses (>10 mg prednisone daily or equivalent) within 4 weeks prior to the first dose of REGN2810; Infection with human ...

6. An Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis - Mayo Clinic

   Treatment with corticosteroids at a dose that exceeds the prednisone equivalent of 40 mg per day;; Treatment with immunosuppressive agents (e.g. ...

7. A Study to Compare CMP-001 Combined with Nivolumab to Nivolumab Alone in Advanced Melanoma Subjects - Mayo Clinic

   ... prednisone within 30 days before the first dose of study treatment on W1D1: Subjects who are currently receiving steroids at a prednisone-equivalent dose of ...

8. Health Topics - Mayo Clinic News Network

   The burden of cancer is different for everyone, and life stages can play a role in how it affects people. For adolescents and young adults[...] ...

9. Efficacy and Safety of Benralizumab in EGPA Compared to Mepolizumab - Mayo Clinic

   Must be on a stable dose of oral prednisolone or prednisone of ≥7.5 mg/day (but not \>50mg/day) for at least 4 weeks prior to randomization. 5. If ...

10. Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia - Mayo Clinic

    ... prednisone or equivalent corticosteroid at the time of registration. Eastern Cooperative Oncology Group (ECOG) performance status 0-2; Patients with active ...